PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.05%
Negative revenue growth while 5715.T stands at 14.94%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-14.49%
Negative gross profit growth while 5715.T is at 18.97%. Joel Greenblatt would examine cost competitiveness or demand decline.
-42.44%
Negative EBIT growth while 5715.T is at 43.98%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-32.96%
Negative operating income growth while 5715.T is at 45.06%. Joel Greenblatt would press for urgent turnaround measures.
-59.68%
Negative net income growth while 5715.T stands at 43.29%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-58.66%
Negative EPS growth while 5715.T is at 43.31%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-58.66%
Negative diluted EPS growth while 5715.T is at 43.31%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.71%
Negative 10Y revenue/share CAGR while 5715.T stands at 72.03%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-90.71%
Negative 5Y CAGR while 5715.T stands at 72.03%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-15.81%
Negative 3Y CAGR while 5715.T stands at 2.81%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
101.62%
Net income/share CAGR at 75-90% of 5715.T's 134.40%. Bill Ackman would press for strategic moves to boost long-term earnings.
101.62%
5Y net income/share CAGR at 75-90% of 5715.T's 134.40%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
-75.64%
Negative 3Y CAGR while 5715.T is 240.15%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-71.80%
Negative equity/share CAGR over 10 years while 5715.T stands at 22.80%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-71.80%
Negative 5Y equity/share growth while 5715.T is at 22.80%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
120.78%
3Y equity/share CAGR above 1.5x 5715.T's 19.28%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.02%
AR growth is negative/stable vs. 5715.T's 2.88%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-36.90%
Inventory is declining while 5715.T stands at 7.82%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-15.23%
Negative asset growth while 5715.T invests at 4.35%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.93%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-44.57%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-2.75%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.